重症监护病房HFNC治疗COVID-19患者疗效评价

A. M. Karcıoğlu, Hatice Atlı, O. Karcıoğlu, Işıl Özkoçak Turan
{"title":"重症监护病房HFNC治疗COVID-19患者疗效评价","authors":"A. M. Karcıoğlu, Hatice Atlı, O. Karcıoğlu, Işıl Özkoçak Turan","doi":"10.4274/tybd.galenos.2022.52244","DOIUrl":null,"url":null,"abstract":"Objective: Since the COVID-19 pandemic caused respiratory failure in many patients, oxygen delivery methods had to be diversified, and their numbers increased. High flow nasal cannula (HFNC), which has been shown beneficial in acute respiratory failure previously, also came to the fore. We aimed to investigate the efficacy of HFNC on patients hospitalized in intensive care units due to COVID-19. Materials and Methods: We retrospectively screened the patients followed in the intensive care unit due to COVID-19. Patients treated with HFNC performed the study group. We analyzed the relationship between demographics, laboratory results, treatment modalities, complications, and outcomes. Results: Among the 330 patients included mean ventilation duration with HFNC was 7.84 days. 170 (51.5%) patients intubated during HFNC treatment. Only 5 of them were extubated. Intubated patients had higher mean HFNC duration (9.74 days - min: 2, max: 49) compared to nonintubated patients (6.05 days - min: 1, max: 30). There was a significant relationship between mortality and age (OR: 1.04), APACHE II score (OR: 1.35), having cancer (OR: 3.89), receiving NIV (OR: 5.94), and presence of secondary bacterial infection (OR: 44.6). Conclusion: HFNC, whose benefit in acute respiratory failure has been proven, is also widely and successfully used in COVID-19 patients. Comprehensive randomized studies are needed to demonstrate the effect of HFNC use on intubation requirement and mortality. [ FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2022-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Evaluation of COVID-19 Patients Treated with HFNC in ICU\",\"authors\":\"A. M. Karcıoğlu, Hatice Atlı, O. Karcıoğlu, Işıl Özkoçak Turan\",\"doi\":\"10.4274/tybd.galenos.2022.52244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Since the COVID-19 pandemic caused respiratory failure in many patients, oxygen delivery methods had to be diversified, and their numbers increased. High flow nasal cannula (HFNC), which has been shown beneficial in acute respiratory failure previously, also came to the fore. We aimed to investigate the efficacy of HFNC on patients hospitalized in intensive care units due to COVID-19. Materials and Methods: We retrospectively screened the patients followed in the intensive care unit due to COVID-19. Patients treated with HFNC performed the study group. We analyzed the relationship between demographics, laboratory results, treatment modalities, complications, and outcomes. Results: Among the 330 patients included mean ventilation duration with HFNC was 7.84 days. 170 (51.5%) patients intubated during HFNC treatment. Only 5 of them were extubated. Intubated patients had higher mean HFNC duration (9.74 days - min: 2, max: 49) compared to nonintubated patients (6.05 days - min: 1, max: 30). There was a significant relationship between mortality and age (OR: 1.04), APACHE II score (OR: 1.35), having cancer (OR: 3.89), receiving NIV (OR: 5.94), and presence of secondary bacterial infection (OR: 44.6). Conclusion: HFNC, whose benefit in acute respiratory failure has been proven, is also widely and successfully used in COVID-19 patients. Comprehensive randomized studies are needed to demonstrate the effect of HFNC use on intubation requirement and mortality. [ FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)\",\"PeriodicalId\":40562,\"journal\":{\"name\":\"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/tybd.galenos.2022.52244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/tybd.galenos.2022.52244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

目的:新型冠状病毒肺炎(COVID-19)大流行导致大量患者呼吸衰竭,给氧方式多样化,给氧方式增多。高流量鼻插管(HFNC)在急性呼吸衰竭治疗中也被证明是有益的。我们的目的是探讨HFNC对COVID-19重症监护病房住院患者的疗效。材料与方法:回顾性筛选重症监护病房因COVID-19随访的患者。采用HFNC治疗的患者为研究组。我们分析了人口统计学、实验室结果、治疗方式、并发症和结果之间的关系。结果:330例患者中HFNC的平均通气时间为7.84天。170例(51.5%)患者在HFNC治疗期间插管。其中只有5人拔管。插管患者的平均HFNC持续时间(9.74天-最短2天,最长49天)高于未插管患者(6.05天-最短1天,最长30天)。死亡率与年龄(OR: 1.04)、APACHE II评分(OR: 1.35)、是否患有癌症(OR: 3.89)、是否接受NIV (OR: 5.94)、是否存在继发性细菌感染(OR: 44.6)存在显著相关。结论:HFNC治疗急性呼吸衰竭的疗效已被证实,在COVID-19患者中也得到了广泛而成功的应用。需要全面的随机研究来证明HFNC对插管需求和死亡率的影响。[来自作者]土耳其重症监护杂志版权归Galenos Yayinevi Tic所有。有限公司未经版权所有者的明确书面许可,STI及其内容不得复制或通过电子邮件发送到多个网站或发布到listserv。但是,用户可以打印、下载或通过电子邮件发送文章供个人使用。这可以删节。对副本的准确性不作任何保证。用户应参阅原始出版版本的材料的完整。(版权适用于所有人。)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Evaluation of COVID-19 Patients Treated with HFNC in ICU
Objective: Since the COVID-19 pandemic caused respiratory failure in many patients, oxygen delivery methods had to be diversified, and their numbers increased. High flow nasal cannula (HFNC), which has been shown beneficial in acute respiratory failure previously, also came to the fore. We aimed to investigate the efficacy of HFNC on patients hospitalized in intensive care units due to COVID-19. Materials and Methods: We retrospectively screened the patients followed in the intensive care unit due to COVID-19. Patients treated with HFNC performed the study group. We analyzed the relationship between demographics, laboratory results, treatment modalities, complications, and outcomes. Results: Among the 330 patients included mean ventilation duration with HFNC was 7.84 days. 170 (51.5%) patients intubated during HFNC treatment. Only 5 of them were extubated. Intubated patients had higher mean HFNC duration (9.74 days - min: 2, max: 49) compared to nonintubated patients (6.05 days - min: 1, max: 30). There was a significant relationship between mortality and age (OR: 1.04), APACHE II score (OR: 1.35), having cancer (OR: 3.89), receiving NIV (OR: 5.94), and presence of secondary bacterial infection (OR: 44.6). Conclusion: HFNC, whose benefit in acute respiratory failure has been proven, is also widely and successfully used in COVID-19 patients. Comprehensive randomized studies are needed to demonstrate the effect of HFNC use on intubation requirement and mortality. [ FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comment on “Stewart’s Approach for Acid-base Disorders: Does the Strong Ion Difference and Effects Have an Impact on Intensive Care Unit Mortality?” Turkish Publications in Science Citation Index and Citation Index-expanded Indexed Journals in the Field of Intensive Care: A Bibliographic Analysis Bacteremia and Pneumoniae Caused by Kocuria Kristinae: A Rare Case Occupatıonal Therapy in Intensive Care Sequential Application of Oxygen Therapy via High-flow Nasal Cannula and Non-invasive Ventilation in COVID-19 Patients with Acute Respiratory Failure in the Intensive Care Unit: A Prospective, Observational Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1